Citigroup Reiterates “Buy” Rating for Stryker (NYSE:SYK)
Stryker (NYSE:SYK – Get Free Report)‘s stock had its “buy” rating restated by analysts at Citigroup in a report released on Thursday, MarketBeat.com reports. They currently have a $455.00 price objective on the medical technology company’s stock, up from their previous price objective of $443.00. Citigroup’s price target would indicate a potential upside of 20.69% […]
Stryker (NYSE:SYK – Get Free Report)‘s stock had its “buy” rating restated by analysts at Citigroup in a report released on Thursday, MarketBeat.com reports. They currently have a $455.00 price objective on the medical technology company’s stock, up from their previous price objective of $443.00. Citigroup’s price target would indicate a potential upside of 20.69% […]
